• (PLX AI) – Oncopeptides dropped another 37% today, adding to massive losses from Friday as more analysts cut the stock after the company withdrew Pepaxto from the U.S. market.
  • • Cut to sell from buy at DNB
  • • Cut to hold from buy at Carnegie
  • • Price target cut to SEK 0.35 from SEK 12 at SEB (sell reiterated)
  • • Investor confidence has evaporated, DNB said
  • • Most likely the company will need to raise cash, which may prove to be a challenge: DNB

Quelle: PLX AI